| EMA number | EMEA/H/C/001047 |
| ATC code | L04AC08 |
| Authorisation | 23 October 2009 |
| Withdrawn | 24 October 2012 |
| Revision | 5 |
Rilonacept Regeneron is indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS) with severe symptoms, including familial cold auto-inflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS), in adults and children aged 12 years and older.